Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McInnes

Showing results (321-330 of 537) with videos related to

Pageof 54
Sort By:
Rheumatology (Oxford, England)|September 14, 2022
Comparative effectiveness of guselkumab in psoriatic arthritis: updates to a systematic literature review and network meta-analysisPhilip J Mease, Iain B McInnes, Lai-Shan Tam, et al.
Plos One|April 24, 2019
Fibroblast activation and inflammation in frozen shoulderMoeed Akbar, Michael McLean, Emma Garcia-Melchor, et al.
Annals of the Rheumatic Diseases|November 20, 2012
Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL studyArthur Kavanaugh, Iain B McInnes, Philip J Mease, et al.
The Journal of Investigative Dermatology|May 29, 2025
Pharmacological Characterization of Zasocitinib (TAK-279): An Oral, Highly Selective, and Potent Allosteric TYK2 InhibitorShailly Mehrotra, Yasuyo Sano, Petro Halkowycz, et al.
ACR Open Rheumatology|July 30, 2024
Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52-Week Results From Two Phase 3 StudiesIain B McInnes, Philip J Mease, Yoshiya Tanaka, et al.
RMD Open|November 9, 2023
MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitisChristina Charles-Schoeman, Ernest Choy, Iain B McInnes, et al.
Arthritis and Rheumatism|December 1, 2011
Co-opting endogenous immunoglobulin for the regulation of inflammation and osteoclastogenesis in humans and miceLindsay M MacLellan, Jennifer Montgomery, Fujimi Sugiyama, et al.
Annals of the Rheumatic Diseases|October 6, 2011
Hypoxia: a critical regulator of early human tendinopathyNeal L Millar, James H Reilly, Shauna C Kerr, et al.
Molecular Oral Microbiology|September 16, 2014
Periodontitis in the absence of B cells and specific anti-bacterial antibodyJ Oliver-Bell, J P Butcher, J Malcolm, et al.
RMD Open|February 24, 2023
Low rates of radiographic progression associated with clinical efficacy following up to 2 years of treatment with guselkumab: results from a phase 3, randomised, double-blind, placebo-controlled study of biologic-naïve patients with active psoriatic arthritisAlice B Gottlieb, Iain B McInnes, Proton Rahman, et al.
Pageof 54

Showing results (321-330 of 537) with videos related to

Sort By:
Pageof 54
Rheumatology (Oxford, England)|September 14, 2022
Comparative effectiveness of guselkumab in psoriatic arthritis: updates to a systematic literature review and network meta-analysisPhilip J Mease, Iain B McInnes, Lai-Shan Tam, et al.
Plos One|April 24, 2019
Fibroblast activation and inflammation in frozen shoulderMoeed Akbar, Michael McLean, Emma Garcia-Melchor, et al.
Annals of the Rheumatic Diseases|November 20, 2012
Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL studyArthur Kavanaugh, Iain B McInnes, Philip J Mease, et al.
The Journal of Investigative Dermatology|May 29, 2025
Pharmacological Characterization of Zasocitinib (TAK-279): An Oral, Highly Selective, and Potent Allosteric TYK2 InhibitorShailly Mehrotra, Yasuyo Sano, Petro Halkowycz, et al.
ACR Open Rheumatology|July 30, 2024
Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52-Week Results From Two Phase 3 StudiesIain B McInnes, Philip J Mease, Yoshiya Tanaka, et al.
RMD Open|November 9, 2023
MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitisChristina Charles-Schoeman, Ernest Choy, Iain B McInnes, et al.
Arthritis and Rheumatism|December 1, 2011
Co-opting endogenous immunoglobulin for the regulation of inflammation and osteoclastogenesis in humans and miceLindsay M MacLellan, Jennifer Montgomery, Fujimi Sugiyama, et al.
Annals of the Rheumatic Diseases|October 6, 2011
Hypoxia: a critical regulator of early human tendinopathyNeal L Millar, James H Reilly, Shauna C Kerr, et al.
Molecular Oral Microbiology|September 16, 2014
Periodontitis in the absence of B cells and specific anti-bacterial antibodyJ Oliver-Bell, J P Butcher, J Malcolm, et al.
RMD Open|February 24, 2023
Low rates of radiographic progression associated with clinical efficacy following up to 2 years of treatment with guselkumab: results from a phase 3, randomised, double-blind, placebo-controlled study of biologic-naïve patients with active psoriatic arthritisAlice B Gottlieb, Iain B McInnes, Proton Rahman, et al.
Pageof 54